Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
7.68
-0.22 (-2.78%)
At close: Feb 27, 2026, 4:00 PM EST
7.70
+0.02 (0.26%)
After-hours: Feb 27, 2026, 7:57 PM EST
Upstream Bio Market Cap
Upstream Bio has a market cap or net worth of $415.02 million as of February 27, 2026. Its market cap has increased by 8.15% in one year.
Market Cap
415.02M
Enterprise Value
44.01M
1-Year Change
8.15%
Ranking
Category
Stock Price
$7.68
Market Cap Chart
Since the IPO on October 11, 2024, Upstream Bio's market cap has increased from $393.35M to $415.02M, an increase of 5.51%. That is a compound annual growth rate of 3.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 415.29M | -71.69% |
| Dec 31, 2025 | 1.47B | 66.51% |
| Dec 31, 2024 | 881.13M | 124.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PepGen | 439.99M |
| Tectonic Therapeutic | 432.53M |
| REGENXBIO | 431.81M |
| Entrada Therapeutics | 429.62M |
| Niagen Bioscience | 426.88M |
| Enanta Pharmaceuticals | 424.84M |
| LENZ Therapeutics | 413.65M |
| Absci | 412.02M |